| Bio-Technology Market Industry |
|---|
| More Pages: Page: (1) |
| OTC PK:BCLI | Brainstorm Cell Therapeutics, Inc. | | | Brainstorm Cell Therapeutics, Inc. develops NurOwn cell therapy products sourced from adult stem cells for treatment of neurodegenerative diseases. It primarily focuses on the development of bone marrow derived neural-like cells for Parkinson's disease. Brainstorm Cell Therapeutics is also developing embryonic stem cells and adult stem cells for multiple cell therapy products. The company was incorporated in 2000 under the name Wizbang Technologies, Inc. and changed its name to Golden Hand Resources, Inc. in 2003. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 130,871 | $0.19 | -5.0% | | |
| OTC PK:CEPO | CepTor Corporation | | | CepTor Corporation is a biopharmaceutical company focused on the development of proprietary, cell-targeted therapeutic products for neuromuscular and neurodegenerative diseases. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 0 | $0.002 | 0.0% | | |
| NYSE:GTF | Cytomedix, Inc. | | | Co. is a biotechnology company whose business model is premised upon developing, producing, and licensing autologous cellular therapies (i.e., therapies using the patient's own body products) for the treatment of chronic non-healing wounds using its propriety platelet gel and related product therapies. To create the proprietary platelet gel product, the patient's own platelets and other essential blood components for the healing process are separated through centrifugation and formed into a gel (the "AutoloGel ") that is topically applied to a wound under the direction of a physician. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 49,480 | $0.595 | -0.8334% | | |
| OTC PK:KWBT | Kiwa Bio-Tech Products Group Corporation | | | Kiwa Bio-Tech Products Group develops, manufactures, distributes and markets bio-technological products for agriculture. Co.'s main product groups are bio-fertilizer, biologically enhanced livestock feed, as well as animal drugs and disinfectants. Co.'s products are designed to enhance the quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 444,000 | $0.0037 | +2.7777% | | |
| OTC PK:NVBG | Nova BioGenetics, Inc. | | | Nova Biogenetics, Inc. is a privately-held biopharmaceutical company headquartered in Atlanta, Georgia that is engaged in the discovery, development, and commercialization of new therapeutic agents. Nova Biogenetics’ pipeline is based on patented technology used as a broad base for applications with existing antibiotic compounds. Attaching the patented technology with antibiotic compounds are intended to facilitate potential disruption of bacterial agents. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 0 | $0.0045 | 0.0% | | |
| More Pages: Page: (1) |
|
| More |
|---|
Investing by Industry or Market Sector employs non-emotional, numbers driven, value-based industry, sector, and country rotation techniques, that, unlike conventional stock picking methods, focuses instead on identifying and capitalizing on theme movements in the well identified industries & market sectors.
Primarily, this active-asset methodology recognizes that advances in financial markets are defined by "themes", or led by asset classes, industries, and countries, with each advance distinguished by specific sector-driven themes. Employing a disciplined research and valuation process these "themes" are identified so that Portfolio's can be created and/or adjusted toward the most attractive sectors.
|
|
